Medicare and Medicaid
Our work in Medicare and Medicaid
-
Without a Cap, Out-of-Pocket Drug Spending Poses Great Risk
Medicare Part D distinctly lacks a cap on out-of-pocket spending, sending many beneficiaries toward financial hazard.
Categorized in -
Will California Be Ready? Implementing Programs for Serious Illness
National and state experts examined California’s readiness to meet the needs of patients with serious illness going forward and trends in this population.
Categorized in -
Improving Bundled Payments in the Medicare Program
John Romley and Paul Ginsburg look at three ways to improve the effectiveness of bundled payment systems.
Categorized in -
The Case for Reforming Competitive Bidding in Medicare Advantage
Schaeffer Initiative experts propose reforming the way that fixed monthly payments to MA plans are determined, replacing the current, overly complex structure with one that would enhance competition, simplify beneficiary choice through standardization, and save an estimated $10 billion annually.
Categorized in -
A Proposal to Enhance Competition and Reform Bidding in the Medicare Advantage Program
Schaeffer Initiative researchers propose two key changes to the MA bidding process to lower prices and enhance choice for consumers.
Categorized in -
Cost-Effectiveness of Multidisciplinary Care in Mild to Moderate Chronic Kidney Disease in the United States: A Modeling Study
Multidisciplinary care (MDC) programs have been proposed as a way to alleviate the cost and morbidity associated with chronic kidney disease (CKD) in the US. Schaeffer fellow Eugene Lin estimates that a Medicare-funded MDC program could improve health outcomes.
Categorized in -
Do States Regret Expanding Medicaid?
Mark Hall finds that across the political spectrum, states that expanded Medicaid do not regret that decision.
-
Trends in Opioid Use and Prescribing in Medicare, 2006-2012
More than 1 in 3 beneficiaries filled an opioid prescription annually; about 1 in 10 were chronic opioid users.
Categorized in -
Congress Should Replace Medicare’s Merit-Based Incentive Payment System
Editor’s note: This piece was originally published at Health Affairs Blog on February 26, 2018. In 2015, Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA) on a strong bipartisan vote. In addition to repealing the Sustainable Growth Rate formula that was used to set the level of physician payment rates, MACRA changed the […]
Categorized in -
Patient Cost-Sharing for Prescription Drugs: Policy Issues
The USC-Brookings Schaeffer Initiative for Health Policy will host a conference on the policy issues surrounding patient drug cost sharing. Two panels will convene, first to discuss restructuring the Medicare Part D benefit design, and then to debate the effectiveness of mechanisms to reduce cost sharing for commercially insured patients.
Categorized in
You must be logged in to post a comment.